Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

In the latest trading session, CVS Health (CVS) closed at $76.08, marking a -0.29% move from the previous day.

CVS Health (CVS) Stock Moves -0.29%: What You Should Know

Amgen

Bayer AG

Cardinal Health

Gilead Sciences

General Mills

Henkel AG & Co KGaA

Novo Nordisk

Reckitt Benckiser Group PLC

Walgreens

In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots Alliance, CVS Health, Cardinal Health and Bayer.

Hunting For Recession-Proof Bargains: 10 Picks As Prey

CVS Health Corp. said Monday that it will start administering COVID-19 vaccinations in four additional states starting March 31. The new locations include five pharmacies in New Mexico; two each in West Virginia and Delaware; and six in Washington.

CVS to start administering COVID-19 vaccinations in 4 additional states on March 31

WOONSOCKET, R.I., March 29, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, March 31 at two select CVS Pharmacy locations in Delaware.

CVS Health to Administer No-Cost COVID-19 Vaccines at Select CVS Pharmacy Locations in Delaware

WOONSOCKET, R.I., March 29, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, March 31 at five select CVS Pharmacy locations in New Mexico.

CVS Health to Administer No-Cost COVID-19 Vaccines at Select CVS Pharmacy Locations in New Mexico

WOONSOCKET, R.I., March 29, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, March 31 at six select CVS Pharmacy locations in Washington.

CVS Health to Administer No-Cost COVID-19 Vaccines at Select CVS Pharmacy Locations in Washington

WOONSOCKET, R.I., March 29, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, March 31 at two select CVS Pharmacy locations in West Virginia.

CVS Health to Administer No-Cost COVID-19 Vaccines at Select CVS Pharmacy Locations in West Virginia

CVS Group PLC (LON:CVSG) said the positive trends seen in the first half of the year have continued in the second half. The veterinary services company said like-for-like sales were up 8% in the eight months to February 29, with stable clinical staff retention as the vet vacancy rate averaged 7.5%, which leads to improved margins.

CVS Group posts positive revenue trends after strong half-year

Healthpeak Properties Inc

Duke Energy

Enbridge

Enterprise Products Partners

Kinder Morgan

LTC Properties

Magellan Midstream Partners

National Retail Properties

Realty Income Corp

Pembina Pipeline

Prologis

AT&T

Unilever

Verizon

W. P. Carey

Exxon Mobil

Kiplinger Investing periodically lists retirement tips. This 41 stock list comes from two articles. One by Brian Bollinger, updated 8/5/20 and another by Charles Lewis Sizemore, CFA, 7/2/19. The articles are, '20 for 20 retirement years', and '25 stocks every retiree should own'. Four stocks are listed twice, leaving 41. One ceased paying dividends and one never did, leaving 39.

11 Reliable Retiree Dividend Stocks Stand Tall In March

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Why Is CVS Health (CVS) Up 1.8% Since Last Earnings Report?

AutoZone

Burlington Stores

Home Depot

O'Reilly Automotive

Ross Stores

Some retail stocks stock performed well in 2020, but many of these companies still face big challenges that they may not be able to overcome. The post 7 Retail Stocks That Are Far Too Close to Failing appeared first on InvestorPlace.

7 Retail Stocks That Are Far Too Close to Failing

What's the prognosis for CVS stock? Here is what the fundamentals and technical analysis say about buying CVS stock now.

CVS Nears Buy Point — But Is It A Buy Right Now? Here's What Earnings, Charts Show

Comcast

NRG Energy

Sherwin-Williams

Helen of Troy

Masco

Mohawk Industries

McCormick

Momo

With the trading day about halfway over, the broad markets seemed to be dragging. The Nasdaq was facing the worst of it, with the index down about 1%.

Comcast, CVS, NRG Energy, Sherwin-Williams and More Wednesday Afternoon Analyst Calls

CVS Heath's (CVS) antibody testing to be available in nearly 60 MinuteClinic locations and cost $38.

CVS Health (CVS) Extends COVID-19 Testing in Massachusetts

WOONSOCKET, R.I., March 16, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the availability of COVID-19 antibody testing in all MinuteClinic locations in Massachusetts.

CVS Health Announces Availability of COVID-19 Antibody Testing in all MinuteClinic Locations in Massachusetts

WOONSOCKET, R.I., March 16, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the availability of COVID-19 antibody testing in all MinuteClinic locations in Texas.

CVS Health Announces Availability of COVID-19 Antibody Testing in all MinuteClinic Locations in Texas

CVS Health Corp. said Tuesday that it is now offering COVID-19 antibody tests at all MinuteClinic locations in Massachusetts and Texas. MinuteClinics are CVS' retail medical locations.

CVS offering COVID anitbody test at all Massachusetts and Texas clinic locations

Starting Saturday, eligible residents in another 12 states can begin booking COVID-19 vaccinations at CVS pharmacy. This week, the vaccines rolled out to CVS locations in Colorado, Illinois, Kentucky, Missouri, Montana, North Carolina, North Dakota, Nevada, Oklahoma, Utah, Minnesota, and Vermont.

CVS expands its COVID-19 vaccine program to 29 states as more doses become available

CVS Health Corporation, with its nearly 9,900 retail locations and 1,100 MinuteClinic locations, could be the ideal venue to vaccinate America.

CVS Expands Vaccination To These 29 States

CVS has added 12 new states to its Covid-19 vaccine rollout as more supply becomes available.

CVS expands Covid-19 vaccine to 12 more states

CVS Health Corp. said Thursday that it will begin administering COVID-19 vaccines at additional sites nationwide, including seven locations in Illinois and Hawaii, 37 additional locations in New York, 119 locations in California, and 34 locations in Massachusetts. Vaccinations for eligible populations at some of these new locations could begin as soon as March 14.

CVS adds locations where it's administering COVID-19 vaccines nationwide

WOONSOCKET, R.I., March 11, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) has nearly doubled the number of states where select CVS Pharmacy locations are offering COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program (FRPP).

CVS Health Now Offering COVID-19 Vaccines in 29 States

The FY 2021 outlook for CVS Health is mixed, with strength in the retail/LTC and pharmacy services businesses expected to be offset by weakness in the health care benefits segment. My target price of $97.20 for CVS Health is based on a 12 times forward P/E multiple applied to FY 2022 consensus earnings, which implies a 35% upside.

CVS Stock: Buy, Sell, Or Hold In 2021

Target Corp. announced Wednesday that more than 600 stores with CVS Health Corp. locations will administer COVID-19 vaccinations. Target and CVS have already partnered for flu, shingles and pneumonia vaccinations.

CVS locations in Target stores will begin administering COVID019 vaccinations

Bank of New York Mellon

Amdocs

MetLife

Rio Tinto plc Sponsored

It's been a shark sell-off lately, especially with tech companies. The time might be right to look at value stocks.

News for CVS Health Stock (CVS)